BRIEF-Basilea indicated up 7.8 pct after drug approval

ZURICH Wed Oct 23, 2013 2:03am EDT

Related Topics

ZURICH Oct 23 (Reuters) - Basilea Pharmaceutica AG : * Shares indicated 7.8 percent higher after clinching EU approval for

ceftobiprole

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.